Total Funding
40
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 40 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
143368
ADC BIO is an innovative biotechnology company. Specialising in Antibody Drug Conjugates.
Acquired by 
Sterling Pharma Solutions
- David Evans: CTO
- Colin Mckee: Head of Technical Services
About the Company
ADC Bio is developing new process technology to help drug developers meet conjugation process challenges in the testing and production of new antibody drug conjugate (ADC)-based anti cancer drugs. The technology signals faster, simpler and less costly development for an exciting new family of drugs.

